Loading...

Since its founding over two decades ago, this Neuro-Developmental Optometry practice has become a leader in treating Binocular Vision Disorders, including Convergence Insufficiency, Amblyopia, and Strabismus. The business is recognized for delivering exceptional visual rehabilitation services, with the majority of revenue generated through fee-for-service arrangements, ensuring high profitability and minimal reliance on insurance reimbursements.
The loyal team, primarily composed of experienced vision therapists, has been with the practice for more than ten years, ensuring continuity of care and operational stability. The practice attracts patients from a wide geographic area, including Pennsylvania, Washington, D.C., Frederick, the Eastern Shore, and Bel Air. It accepts Aetna and Blue Cross Blue Shield for major medical plans, while 20% of the 120 active vision therapy patients choose self-pay, further supporting robust cash flow.
The practice averages approximately 640 vision patient visits per month, with vision therapy sessions as the primary income driver. In 2023, over 7,700 sessions were performed at an average of $150 per session. The owner currently maintains a four-day work week, underscoring the practice’s efficiency and potential for work-life balance or further growth.
Due to seller confidentiality, detailed balance sheets, customer concentration, tax returns, and supplier agreements require executing our digital bilateral NDA.
Free for qualified buyers & acquisition searchers.
Calculate fair market enterprise value and compare EBITDA multiples against industry benchmarks.
Launch Valuation Calculator